Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
Andreas Luttens(Science for Life Laboratory), Jens Carlsson(Uppsala University), Hjalmar Gullberg(Stockholm University), Åke Lundkvist(Uppsala University), Dario Akaberi(Uppsala University), Steven De Jonghe(Rega Institute for Medical Research), Lindon W. K. Moodie(Uppsala University), Laura Vangeel(VIB-KU Leuven Center for Brain & Disease Research), Kristian Sandberg(Uppsala University), Natalia Nekhotiaeva(Stockholm University), Janina Krambrich(Uppsala University), Jan Kihlberg(Uppsala University), Duy Duc Vo(Uppsala University), Alexander J. Craig(Uppsala University), Johan Lennerstrand(Uppsala University), Dirk Jochmans(Rega Institute for Medical Research), Yoseph Atilaw(Uppsala University), Martijn J. van Hemert(Leiden University Medical Center), Eldar Abdurakhmanov(Uppsala University), Ylva Gravenfors(Stockholm University), Johan Neyts(Rega Institute for Medical Research), U. Helena Danielson(Uppsala University), Anja Sandström(Uppsala University), V. Talibov(Uppsala University), Ali Taş(Leiden University Medical Center), Bo Lundgren(Stockholm University)
Cited by 244
Related Papers
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
|PLoS Pathogens|2010|915
A practical guide to large-scale docking
|Nature Protocols|2021|540
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
|Antiviral Research|2022|430
Ligand discovery from a dopamine D3 receptor homology model and crystal structure
|Nature Chemical Biology|2011|303
Proton Binding to Proteins: p <i>K</i> <sub>a</sub> Calculations with Explicit and Implicit Solvent Models
|Journal of the American Chemical Society|2004|283